A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/46 (2006.01) A61K 31/00 (2006.01) A61K 33/00 (2006.01) A61K 33/06 (2006.01) A61K 33/14 (2006.01) A61P 11/00 (2006.01)
Patent
CA 2443107
The equilibrium between G actin and F actin is shifted towards the F actin confirmation with compounds such as the ionic form of magnesium or potassium. The higher amount of F actin decreases the inhibition of nucleases such as DNAse I by monomeric G actin. The increased performance of the nuclease results in better treatment of patients suffering from cystic fibrosis or other diseases associated with viscous mucus.
L'invention concerne l'actine G et l'actine F dont l'équilibre est remplacé par l'affirmation de l'actine F grâce à des composés tels que la forme ionique du magnésium ou du potassium. La quantité supérieure d'actine réduit l'inhibition des nucléases telles que la DNAse I par l'actine G monomérique. L'efficacité améliorée de la nucléase permet de mieux traiter les patients souffrant de fibrose cystique ou d'autres maladies associées au mucus visqueux.
de Smedt Stefaan
Demeester Joseph
Sanders Niek
Smart & Biggar
Universiteit Gent
LandOfFree
Therapeutic compositions for the treatment of a respiratory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic compositions for the treatment of a respiratory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compositions for the treatment of a respiratory... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1419919